1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Liu, G. Poppe, L. Aoki, K. Yamane, H. Lewis, J. Szyperski, T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Plos One 1932-6203 9 e96521 e96521 10.1371/journal.pone.0096521 24789074 High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design. 2014 10.2210/pdb2mhs/pdb pdb_00002mhs 18866.354 Induced myeloid leukemia cell differentiation protein Mcl-1 UNP residues 171-327 C117S 1 man polymer Bcl-2-like protein 3, Bcl2-L-3, Bcl-2-related protein EAT/mcl1, mcl1/EAT no no MEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRV MIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESSIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGHH HHHH MEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRV MIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESSIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGHH HHHH A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample MCL1, BCL2L3 9606 Homo sapiens 562 Escherichia coli plasmid pSR482-21.1 database_2 pdbx_database_status struct_ref_seq_dif repository Initial release Database references Other 1 0 2014-05-14 1 1 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _struct_ref_seq_dif.details BMRB Y RCSB 2013-12-04 REL REL REL REL target function 100 20 3D 15N/13Caliphatic/13Caromatic-resolved NOESY GFT(4,3)D HNNCabCa GFT(4,3)DCabCacoNHN GFT(4,3)D HabCabcoNHN GFT(4,3)D HNNCO GFT (4,3)D HCCH 2D 1H-13C HSQC 2D 1H-15N HSQC 2D 1H-13C HSQC 2D 1H-13C HSQC aromatic 0.7 mM [U-100% 13C; U-100% 15N] 0.7 mM [U-5% 13C; U-100% 15N] 0.3 7.4 ambient 298 K distance geometry, molecular dynamics, simulated annealing, torsion angle dynamics 1 lowest energy 0.7 mM [U-100% 13C; U-100% 15N] mcl-1, 95% H2O/5% D2O 95% H2O/5% D2O 0.7 mM [U-5% 13C; U-100% 15N] mcl-1, 95% H2O/5% D2O 95% H2O/5% D2O Varian collection VNMR Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax processing NMRPipe Bartels et al. data analysis XEASY Zimmerman, Moseley, Kulikowski and Montelione chemical shift assignment AutoAssign Huang, Tejero, Powers and Montelione structure solution AutoStructure Huang, Tejero, Powers and Montelione data analysis AutoStructure Guntert, Mumenthaler and Wuthrich structure solution CYANA Guntert, Mumenthaler and Wuthrich data analysis CYANA Brunger, Adams, Clore, Gros, Nilges and Read structure solution CNS Brunger, Adams, Clore, Gros, Nilges and Read refinement CNS Glaser processing SPSCAN Bhattacharya and Montelione data analysis PSVS 750 Varian INOVA Varian INOVA 600 Varian INOVA Varian INOVA MET 1 n 1 MET 1 A GLU 2 n 2 GLU 2 A ASP 3 n 3 ASP 3 A GLU 4 n 4 GLU 4 A LEU 5 n 5 LEU 5 A TYR 6 n 6 TYR 6 A ARG 7 n 7 ARG 7 A GLN 8 n 8 GLN 8 A SER 9 n 9 SER 9 A LEU 10 n 10 LEU 10 A GLU 11 n 11 GLU 11 A ILE 12 n 12 ILE 12 A ILE 13 n 13 ILE 13 A SER 14 n 14 SER 14 A ARG 15 n 15 ARG 15 A TYR 16 n 16 TYR 16 A LEU 17 n 17 LEU 17 A ARG 18 n 18 ARG 18 A GLU 19 n 19 GLU 19 A GLN 20 n 20 GLN 20 A ALA 21 n 21 ALA 21 A THR 22 n 22 THR 22 A GLY 23 n 23 GLY 23 A ALA 24 n 24 ALA 24 A LYS 25 n 25 LYS 25 A ASP 26 n 26 ASP 26 A THR 27 n 27 THR 27 A LYS 28 n 28 LYS 28 A PRO 29 n 29 PRO 29 A MET 30 n 30 MET 30 A GLY 31 n 31 GLY 31 A ARG 32 n 32 ARG 32 A SER 33 n 33 SER 33 A GLY 34 n 34 GLY 34 A ALA 35 n 35 ALA 35 A THR 36 n 36 THR 36 A SER 37 n 37 SER 37 A ARG 38 n 38 ARG 38 A LYS 39 n 39 LYS 39 A ALA 40 n 40 ALA 40 A LEU 41 n 41 LEU 41 A GLU 42 n 42 GLU 42 A THR 43 n 43 THR 43 A LEU 44 n 44 LEU 44 A ARG 45 n 45 ARG 45 A ARG 46 n 46 ARG 46 A VAL 47 n 47 VAL 47 A GLY 48 n 48 GLY 48 A ASP 49 n 49 ASP 49 A GLY 50 n 50 GLY 50 A VAL 51 n 51 VAL 51 A GLN 52 n 52 GLN 52 A ARG 53 n 53 ARG 53 A ASN 54 n 54 ASN 54 A HIS 55 n 55 HIS 55 A GLU 56 n 56 GLU 56 A THR 57 n 57 THR 57 A ALA 58 n 58 ALA 58 A PHE 59 n 59 PHE 59 A GLN 60 n 60 GLN 60 A GLY 61 n 61 GLY 61 A MET 62 n 62 MET 62 A LEU 63 n 63 LEU 63 A ARG 64 n 64 ARG 64 A LYS 65 n 65 LYS 65 A LEU 66 n 66 LEU 66 A ASP 67 n 67 ASP 67 A ILE 68 n 68 ILE 68 A LYS 69 n 69 LYS 69 A ASN 70 n 70 ASN 70 A GLU 71 n 71 GLU 71 A ASP 72 n 72 ASP 72 A ASP 73 n 73 ASP 73 A VAL 74 n 74 VAL 74 A LYS 75 n 75 LYS 75 A SER 76 n 76 SER 76 A LEU 77 n 77 LEU 77 A SER 78 n 78 SER 78 A ARG 79 n 79 ARG 79 A VAL 80 n 80 VAL 80 A MET 81 n 81 MET 81 A ILE 82 n 82 ILE 82 A HIS 83 n 83 HIS 83 A VAL 84 n 84 VAL 84 A PHE 85 n 85 PHE 85 A SER 86 n 86 SER 86 A ASP 87 n 87 ASP 87 A GLY 88 n 88 GLY 88 A VAL 89 n 89 VAL 89 A THR 90 n 90 THR 90 A ASN 91 n 91 ASN 91 A TRP 92 n 92 TRP 92 A GLY 93 n 93 GLY 93 A ARG 94 n 94 ARG 94 A ILE 95 n 95 ILE 95 A VAL 96 n 96 VAL 96 A THR 97 n 97 THR 97 A LEU 98 n 98 LEU 98 A ILE 99 n 99 ILE 99 A SER 100 n 100 SER 100 A PHE 101 n 101 PHE 101 A GLY 102 n 102 GLY 102 A ALA 103 n 103 ALA 103 A PHE 104 n 104 PHE 104 A VAL 105 n 105 VAL 105 A ALA 106 n 106 ALA 106 A LYS 107 n 107 LYS 107 A HIS 108 n 108 HIS 108 A LEU 109 n 109 LEU 109 A LYS 110 n 110 LYS 110 A THR 111 n 111 THR 111 A ILE 112 n 112 ILE 112 A ASN 113 n 113 ASN 113 A GLN 114 n 114 GLN 114 A GLU 115 n 115 GLU 115 A SER 116 n 116 SER 116 A SER 117 n 117 SER 117 A ILE 118 n 118 ILE 118 A GLU 119 n 119 GLU 119 A PRO 120 n 120 PRO 120 A LEU 121 n 121 LEU 121 A ALA 122 n 122 ALA 122 A GLU 123 n 123 GLU 123 A SER 124 n 124 SER 124 A ILE 125 n 125 ILE 125 A THR 126 n 126 THR 126 A ASP 127 n 127 ASP 127 A VAL 128 n 128 VAL 128 A LEU 129 n 129 LEU 129 A VAL 130 n 130 VAL 130 A ARG 131 n 131 ARG 131 A THR 132 n 132 THR 132 A LYS 133 n 133 LYS 133 A ARG 134 n 134 ARG 134 A ASP 135 n 135 ASP 135 A TRP 136 n 136 TRP 136 A LEU 137 n 137 LEU 137 A VAL 138 n 138 VAL 138 A LYS 139 n 139 LYS 139 A GLN 140 n 140 GLN 140 A ARG 141 n 141 ARG 141 A GLY 142 n 142 GLY 142 A TRP 143 n 143 TRP 143 A ASP 144 n 144 ASP 144 A GLY 145 n 145 GLY 145 A PHE 146 n 146 PHE 146 A VAL 147 n 147 VAL 147 A GLU 148 n 148 GLU 148 A PHE 149 n 149 PHE 149 A PHE 150 n 150 PHE 150 A HIS 151 n 151 HIS 151 A VAL 152 n 152 VAL 152 A GLU 153 n 153 GLU 153 A ASP 154 n 154 ASP 154 A LEU 155 n 155 LEU 155 A GLU 156 n 156 GLU 156 A GLY 157 n 157 GLY 157 A GLY 158 n 158 GLY 158 A HIS 159 n 159 HIS 159 A HIS 160 n 160 HIS 160 A HIS 161 n 161 HIS 161 A HIS 162 n 162 HIS 162 A HIS 163 n 163 HIS 163 A HIS 164 n 164 HIS 164 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 20 A A HH12 HB2 ARG LYS 15 28 1.25 1 A ARG 32 60.98 -80.43 1 A LEU 66 -82.20 -76.05 1 A ASP 67 47.21 91.89 1 A VAL 89 -62.85 -177.54 1 A THR 90 -87.00 -78.99 1 A ASN 91 45.41 89.58 1 A GLN 114 -84.82 45.55 1 A HIS 151 56.65 72.48 1 A VAL 152 -103.16 -68.52 1 A GLU 156 -105.58 -62.64 1 A HIS 160 -154.16 57.73 2 A ALA 24 -140.24 -156.62 2 A PRO 29 -58.23 -77.20 2 A MET 30 174.63 -30.75 2 A LEU 66 -99.94 -69.57 2 A ASP 67 71.70 -48.63 2 A ILE 68 62.97 98.24 2 A THR 90 -77.38 20.57 2 A ASN 91 -68.57 81.00 2 A GLN 114 -92.74 38.86 2 A ARG 141 59.84 80.83 2 A HIS 159 69.86 -61.70 2 A HIS 160 -44.42 103.86 3 A ALA 24 -112.06 -159.89 3 A ARG 32 -104.87 -76.85 3 A LEU 66 -118.90 -73.66 3 A ASP 67 70.45 -43.86 3 A ILE 68 62.83 90.27 3 A THR 90 63.58 -62.11 3 A TRP 92 -69.24 11.32 3 A ARG 141 61.61 60.16 3 A HIS 159 -42.70 107.64 4 A THR 27 -148.67 19.96 4 A LEU 66 -117.18 -76.18 4 A ASP 67 71.12 -40.72 4 A ILE 68 60.42 94.25 4 A PHE 85 -88.57 32.76 4 A GLN 114 -99.61 36.99 4 A ARG 141 62.29 89.71 4 A GLU 156 -140.31 -45.50 5 A MET 30 -117.14 -83.43 5 A ASP 67 54.37 97.71 5 A THR 90 -67.66 86.10 5 A GLN 114 -91.95 40.84 5 A ARG 141 51.49 72.17 5 A HIS 151 65.75 74.83 5 A ASP 154 -102.62 -164.68 5 A GLU 156 -115.99 -71.58 5 A HIS 163 58.00 12.44 6 A THR 27 -143.27 48.55 6 A LEU 66 -95.09 -75.70 6 A ASP 67 43.34 83.37 6 A PHE 85 -82.50 44.05 6 A GLN 114 -91.66 43.27 6 A ARG 141 55.16 74.06 6 A GLU 153 -131.18 -45.29 7 A GLU 2 -164.11 -165.85 7 A THR 27 -141.71 23.98 7 A ARG 32 -86.77 -82.08 7 A LEU 66 -103.85 -73.72 7 A ASP 67 38.26 87.06 7 A GLN 114 -94.76 38.08 7 A THR 132 -130.46 -37.41 7 A HIS 151 71.31 106.54 7 A VAL 152 -142.05 -73.89 8 A THR 27 -151.03 22.46 8 A LEU 66 -82.75 -73.13 8 A ASP 67 45.35 83.40 8 A TRP 92 68.19 -25.89 8 A GLN 114 -81.70 45.42 8 A HIS 151 54.78 86.71 8 A VAL 152 -94.43 -61.30 8 A HIS 162 -163.45 102.65 9 A THR 27 -141.87 33.08 9 A LEU 66 -99.83 -82.38 9 A ASP 67 48.63 98.94 9 A PHE 85 -79.82 42.45 9 A GLN 114 -97.95 31.65 9 A HIS 151 57.61 79.23 9 A VAL 152 -107.09 -68.52 9 A GLU 153 -105.77 67.27 9 A HIS 159 58.38 130.16 10 A LEU 66 -96.35 -71.66 10 A ASP 67 47.46 88.85 10 A GLN 114 -87.52 43.56 10 A ARG 141 55.63 79.02 10 A HIS 151 61.08 88.16 10 A VAL 152 -129.79 -74.93 10 A GLU 153 -116.41 79.82 10 A GLU 156 62.18 -1.43 10 A HIS 160 -78.05 29.18 10 A HIS 161 -172.10 132.94 11 A MET 30 -60.28 -71.08 11 A LEU 66 -97.12 -78.99 11 A ASP 67 68.11 -47.93 11 A ILE 68 65.58 114.82 11 A ILE 112 -95.43 31.78 11 A ASN 113 48.71 22.18 11 A GLN 114 -93.61 35.98 11 A HIS 151 68.19 85.25 11 A VAL 152 -124.02 -71.41 11 A GLU 153 -106.81 67.71 11 A ASP 154 -169.72 -167.06 11 A LEU 155 -147.93 11.56 12 A THR 27 -147.27 37.59 12 A LEU 66 -102.94 -73.97 12 A ASP 67 40.95 84.65 12 A ILE 68 -59.60 104.99 12 A VAL 152 -102.41 -60.21 12 A GLU 156 63.07 84.31 12 A HIS 159 -141.49 55.02 12 A HIS 162 53.92 0.56 13 A THR 27 -144.28 -5.80 13 A ARG 32 -155.64 -76.64 13 A LEU 66 -81.95 -80.82 13 A ASP 67 45.24 90.44 13 A THR 132 -130.18 -30.78 14 A PRO 29 -66.33 72.76 14 A MET 30 37.44 -89.46 14 A ARG 32 -137.66 -64.42 14 A LEU 66 -69.56 -76.72 14 A ASP 67 43.67 85.70 14 A THR 90 -68.61 84.15 14 A GLN 114 -86.22 35.62 14 A THR 132 -131.44 -40.82 14 A ARG 141 60.62 83.78 14 A HIS 151 60.41 81.47 14 A VAL 152 -129.59 -67.39 14 A GLU 153 -119.75 69.42 14 A GLU 156 80.20 -60.85 14 A HIS 160 -55.46 106.50 15 A LEU 66 -89.58 -74.87 15 A ASP 67 34.29 91.03 15 A THR 90 -91.68 52.69 15 A ARG 141 52.81 71.79 15 A GLU 156 -134.08 -67.19 15 A HIS 159 -69.59 91.54 16 A THR 27 -94.76 31.68 16 A LEU 66 -96.23 -69.70 16 A ASP 67 69.63 -52.08 16 A ILE 68 64.94 99.49 16 A SER 86 -78.48 41.60 16 A GLN 114 -82.72 33.69 16 A HIS 151 65.27 71.91 16 A GLU 156 65.68 -13.93 16 A HIS 163 173.38 168.82 17 A THR 27 -149.85 11.51 17 A PRO 29 -49.42 107.15 17 A SER 33 -89.05 -74.67 17 A LEU 66 -95.95 -71.86 17 A ASP 67 44.27 87.73 17 A ASP 87 -60.67 -70.26 17 A TRP 92 63.86 -5.06 17 A LYS 133 -150.33 48.90 17 A VAL 152 -100.33 -69.92 17 A GLU 153 -100.89 68.16 17 A GLU 156 -147.06 -60.22 17 A HIS 160 53.99 18.92 18 A THR 27 -150.44 41.60 18 A LEU 66 -105.92 -84.78 18 A ASP 67 67.75 -22.41 18 A ILE 68 59.34 95.65 18 A ASP 87 -66.02 85.37 18 A GLN 114 -82.87 40.92 19 A THR 27 -152.28 29.13 19 A SER 33 63.55 88.19 19 A LEU 66 -90.25 -77.32 19 A ASP 67 52.52 91.93 19 A ASN 113 47.70 20.41 19 A GLN 114 -89.17 35.71 19 A HIS 151 44.59 86.49 20 A ALA 24 -124.16 -163.89 20 A THR 27 -140.05 25.83 20 A LEU 66 -88.73 -83.47 20 A ASP 67 49.56 94.56 20 A THR 90 -84.94 35.62 20 A ASN 113 48.94 21.73 20 A GLN 114 -90.62 35.88 20 A HIS 151 61.33 78.76 20 A VAL 152 -118.45 -72.05 20 A GLU 156 -134.32 -58.31 NMR Structure of human Mcl-1 1 N N A ASP 3 A ASP 3 HELX_P A GLY 23 A GLY 23 1 1 21 A SER 33 A SER 33 HELX_P A ASP 67 A ASP 67 1 2 35 A ASN 70 A ASN 70 HELX_P A VAL 84 A VAL 84 1 3 15 A ASN 91 A ASN 91 HELX_P A ILE 112 A ILE 112 1 4 22 A GLN 114 A GLN 114 HELX_P A LYS 133 A LYS 133 1 5 20 A LYS 133 A LYS 133 HELX_P A GLN 140 A GLN 140 1 6 8 A ARG 141 A ARG 141 HELX_P A PHE 150 A PHE 150 1 7 10 APOPTOSIS Mcl-1, Bcl-2 family, BH domain, Apoptosis, Cancer drug, GFT NMR MCL1_HUMAN UNP 1 171 Q07820 EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVM IHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG 171 327 2MHS 2 158 Q07820 A 1 2 158 1 initiating methionine MET 1 2MHS A Q07820 UNP 1 1 CYS engineered mutation SER 117 2MHS A Q07820 UNP 286 117 1 expression tag HIS 159 2MHS A Q07820 UNP 159 1 expression tag HIS 160 2MHS A Q07820 UNP 160 1 expression tag HIS 161 2MHS A Q07820 UNP 161 1 expression tag HIS 162 2MHS A Q07820 UNP 162 1 expression tag HIS 163 2MHS A Q07820 UNP 163 1 expression tag HIS 164 2MHS A Q07820 UNP 164